{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:28:22Z","timestamp":1765546102499,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.jcyt.2016.01.009","type":"journal-article","created":{"date-parts":[[2016,4,5]],"date-time":"2016-04-05T05:18:34Z","timestamp":1459833514000},"page":"621-629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Indoleamine 2,3-dioxygenase mediates inhibition of virus-specific CD8+ T cell proliferation by human mesenchymal stromal cells"],"prefix":"10.1016","volume":"18","author":[{"given":"Jian","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Hueckelhoven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Wuchter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Tabarkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Kleist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Bieback","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony D.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2016.01.009_bib0010","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jcyt.2014.04.002","article-title":"Standardization of good manufacturing practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applications","volume":"17","author":"Wuchter","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0015","first-page":"83","article-title":"Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method","volume":"2","author":"Friedenstein","year":"1974","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0020","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1634\/stemcells.2005-0342","article-title":"Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue","volume":"24","author":"Kern","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0025","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/107632701300062859","article-title":"Multilineage cells from human adipose tissue: implications for cell-based therapies","volume":"7","author":"Zuk","year":"2001","journal-title":"Tissue Eng"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0030","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/ten.tec.2008.0031","article-title":"Collection, cryopreservation, and characterization of human dental pulp-derived mesenchymal stem cells for banking and clinical use","volume":"14","author":"Perry","year":"2008","journal-title":"Tissue Eng Part C Meth"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0035","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/icb.2012.56","article-title":"Mechanisms of mesenchymal stromal cell immunomodulation","volume":"91","author":"English","year":"2013","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0045","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/trf.12421","article-title":"Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices","volume":"54","author":"Sharma","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0050","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0055","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1634\/stemcells.2006-0228","article-title":"Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease","volume":"24","author":"Yanez","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0060","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jcyt.2012.10.002","article-title":"The mesenchymal stromal cells dilemma\u2014does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?","volume":"15","author":"Galipeau","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0065","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","article-title":"Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli","volume":"99","author":"Di Nicola","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0070","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1038\/leu.2014.273","article-title":"Mesenchymal stromal cells inhibit proliferation of virus-specific CD8(+) T cells","volume":"28","author":"Malcherek","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0075","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1182\/blood-2007-10-119370","article-title":"Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses","volume":"112","author":"Karlsson","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0080","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/sj.bmt.1705368","article-title":"Mesenchymal stem cells are susceptible to human herpesviruses, but viral DNA cannot be detected in the healthy seropositive individual","volume":"37","author":"Sundin","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0085","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/cr.2008.80","article-title":"A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1","volume":"18","author":"Sheng","year":"2008","journal-title":"Cell Res"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0090","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.molmed.2011.10.004","article-title":"The immunomodulatory capacity of mesenchymal stem cells","volume":"18","author":"Gebler","year":"2012","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0095","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1182\/blood-2003-11-3909","article-title":"Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation","volume":"103","author":"Meisel","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0100","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1089\/scd.2012.0594","article-title":"Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controls","volume":"22","author":"Menard","year":"2013","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/mt.2011.189","article-title":"Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation","volume":"20","author":"Francois","year":"2012","journal-title":"Mol Ther"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0110","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1084\/jem.189.9.1363","article-title":"Inhibition of T cell proliferation by macrophage tryptophan catabolism","volume":"189","author":"Munn","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0115","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1084\/jem.20020052","article-title":"Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites","volume":"196","author":"Terness","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0120","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1097\/TP.0b013e3181fed001","article-title":"Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression","volume":"90","author":"Ge","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0125","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.4049\/jimmunol.176.11.6752","article-title":"The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells","volume":"176","author":"Fallarino","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0130","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/eji.200838729","article-title":"BM stromal cells ameliorate experimental autoimmune myasthenia gravis by altering the balance of Th cells through the secretion of IDO","volume":"39","author":"Kong","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0135","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jcyt.2013.07.007","article-title":"Functional potentials of human hematopoietic progenitor cells are maintained by mesenchymal stromal cells and not impaired by plerixafor","volume":"16","author":"Ludwig","year":"2014","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0140","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1634\/stemcells.2006-0627","article-title":"Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue","volume":"25","author":"Kocaoemer","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0145","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/leu.2011.108","article-title":"Mesenchymal stromal cell \u201clicensing\u201d: a multistep process","volume":"25","author":"Krampera","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0150","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0155","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-2249.2007.03422.x","article-title":"Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells","volume":"149","author":"Ryan","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0160","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/nm.2542","article-title":"Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-gamma and TNF-alpha","volume":"17","author":"Liu","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0165","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/stem.1388","article-title":"IFN-gamma and TNF-alpha synergistically induce mesenchymal stem cell impairment and tumorigenesis via NFkappaB signaling","volume":"31","author":"Wang","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0170","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.bbmt.2011.07.023","article-title":"Long-term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapy","volume":"18","author":"von Bahr","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2016.01.009_bib0175","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/leu.2010.310","article-title":"Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase","volume":"25","author":"Meisel","year":"2011","journal-title":"Leukemia"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324916000347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324916000347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:22:20Z","timestamp":1761430940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324916000347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S1465324916000347"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2016.01.009","relation":{},"ISSN":["1465-3249"],"issn-type":[{"type":"print","value":"1465-3249"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indoleamine 2,3-dioxygenase mediates inhibition of virus-specific CD8+ T cell proliferation by human mesenchymal stromal cells","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2016.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}